Therapeutic Plasma Exchange Eased Refractory MG

Therapeutic Plasma Exchange Eased Refractory MG

302664

Therapeutic Plasma Exchange Eased Refractory MG

Therapeutic plasma exchange improved symptoms related to hard-to-treat myasthenia gravis, resulted in reduced use of immunosuppressants, and was well-tolerated by patients, according to a new study. That study, “Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis,” was published in the Journal of Clinical Apheresis. Although most people with myasthenia gravis (MG) respond well to standard therapies, such as acetylcholinesterase inhibitors, glucocorticosteroids, and immunosuppressants, roughly 10–20% of patients do not. These difficult-to-treat cases are referred…

You must be logged in to read/download the full post.